• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Bioxcel Therap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 98K (forecast USD 216.67K), actual EPS USD -2.1774 (forecast USD -1.34)
04:00
Bioxcel Therap released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 386K, actual EPS USD -6.1244
04:00
Oct16
Selvaraju focuses on healthcare stocks such as Bioxcel Therapeutics
13:02
Sep10
BioXcel Therapeutics Announces Positive Results for BXCL501 Phase 3 Trial
10:32
Aug26
BioXcel Therapeutics to Announce Preliminary Results of Serenity Phase 3 Safety Trial
20:01
Aug18
BioXcel Therapeutics Inc. Launches ATM Program to Sell Up to $80 Million in Common Stock
21:16

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 98 K, Net Income -30.91 M, EPS -2.1774

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 120 K, Net Income -19.19 M, EPS -2.4463

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 168 K, Net Income -7.254 M, EPS -1.5006

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More